Topic: Immunotherapy in Gastrointestinal Tumors

Immunotherapy has revolutionized the treatment landscape of various cancers, including gastrointestinal tumors. With the growing understanding of the immune microenvironment and advancements in immunotherapeutic strategies, there is a significant opportunity to explore the role of immunotherapy in the management of gastrointestinal malignancies. This Special Issue aims to provide a comprehensive overview of the current state of the art in immunotherapy for gastrointestinal tumors, highlighting recent developments, challenges, and future directions in this rapidly evolving field.

Potential Subtopics but not limited:
1. Immune Checkpoint Inhibitors in Gastrointestinal Cancers;
2. Adoptive Cell Therapy for Gastrointestinal Cancers;
3. Immunomodulatory Agents in Gastrointestinal Cancers;
4. Combination Immunotherapy Approaches for Gastrointestinal Cancers;
5. Biomarkers for Predicting Response to Immunotherapy in Gastrointestinal Tumors;
6. Immunotherapy-related Toxicities and Management Strategies;
7. Novel Immunotherapeutic Targets in Gastrointestinal Cancers;
8. Immunotherapy in Rare Gastrointestinal Tumors;
9. Immunotherapy in the Neoadjuvant and Adjuvant Settings for Gastrointestinal Cancers;
10. Future Perspectives and Emerging Trends in Immunotherapy for Gastrointestinal Tumors.

This Special Issue invites original research articles, reviews, perspectives, and clinical studies that contribute to advancing our understanding of immunotherapy in gastrointestinal tumors. We welcome submissions from researchers, clinicians, and experts in the field to share their insights and contribute to the collective knowledge aimed at improving patient outcomes in gastrointestinal oncology.

20 Sep 2024